<p>Viral replication levels (VP1 expression) at different time post infection (hours post infection; hpi) of TO cells, pretreated (24 h) with recombinant IFN-α1. The TA strain shows earlier increase of replication levels (24 hpi) and peak at 48 hpi at 23-fold higher replication levels than the TT-strain at this time point. N = 3–4 replicates per time point.</p
(A-D) BMDMs from WT, MAVS-/-, or IFNAR-/- mice were mock infected or infected with WT or N1347A MHV,...
(A-B) TMZR5 GFP-reporter cells were challenged with matched TF and CC VSV-G pseudotyped IMC pairs an...
<p>(A–C) HDF-TERT cells were infected with <i>dl</i>309 (A), Ad5-WT (B) or Ad5-mut1 (C) at 25 virus ...
<p>LSECs were treated with IFNβ for 24 h and infected with MCMV<sup>r</sup>. (<b>A</b>) Representati...
<div><p>(A) Primary human cell lines (SAECs and NHBEs) were grown to 50% confluence in six-well plat...
<p>(A). Virus titers in IFNβ-producing (VISA<sup>+/+</sup>) and IFNβ-non-producing (VISA<sup>−/−</su...
Vero-E6 cells were treated either with placebo or with 103 UI/mL recombinant universal IFN-α 18 hour...
<p>A) IFNβ mRNA expression at day 4 post-infection in LH86 cells after transfecting with a control s...
<p><b>(A)</b> The schematic representation of VEEV TC-83-based recombinant virus genome (VEEV/GFP/C1...
<p>(A-B) The early IFNβ/λ1<sup>M</sup> induction with varying fold of viral dose treatment. (A) Each...
<p>A) IFNβ mRNA expression was measured daily from the total RNA of LH86 cells treated with an MOI o...
<p>A549 were treated with IFNs for 18-treatment approaches, cells cultured for another 72 h and coll...
<p>A549 were treated with IFNs for 18(n = 6). Fold-changes were calculated with the 2<sup>−ΔΔCt</sup...
<p><i>(A)</i> HeLa cells treated with IFN-β or Poly IC showed fewer signs of cytopathic effects and ...
<p><i>A</i>, Enhanced infection of SeV by neutralization of constitutive IFN-α visualized with IF. C...
(A-D) BMDMs from WT, MAVS-/-, or IFNAR-/- mice were mock infected or infected with WT or N1347A MHV,...
(A-B) TMZR5 GFP-reporter cells were challenged with matched TF and CC VSV-G pseudotyped IMC pairs an...
<p>(A–C) HDF-TERT cells were infected with <i>dl</i>309 (A), Ad5-WT (B) or Ad5-mut1 (C) at 25 virus ...
<p>LSECs were treated with IFNβ for 24 h and infected with MCMV<sup>r</sup>. (<b>A</b>) Representati...
<div><p>(A) Primary human cell lines (SAECs and NHBEs) were grown to 50% confluence in six-well plat...
<p>(A). Virus titers in IFNβ-producing (VISA<sup>+/+</sup>) and IFNβ-non-producing (VISA<sup>−/−</su...
Vero-E6 cells were treated either with placebo or with 103 UI/mL recombinant universal IFN-α 18 hour...
<p>A) IFNβ mRNA expression at day 4 post-infection in LH86 cells after transfecting with a control s...
<p><b>(A)</b> The schematic representation of VEEV TC-83-based recombinant virus genome (VEEV/GFP/C1...
<p>(A-B) The early IFNβ/λ1<sup>M</sup> induction with varying fold of viral dose treatment. (A) Each...
<p>A) IFNβ mRNA expression was measured daily from the total RNA of LH86 cells treated with an MOI o...
<p>A549 were treated with IFNs for 18-treatment approaches, cells cultured for another 72 h and coll...
<p>A549 were treated with IFNs for 18(n = 6). Fold-changes were calculated with the 2<sup>−ΔΔCt</sup...
<p><i>(A)</i> HeLa cells treated with IFN-β or Poly IC showed fewer signs of cytopathic effects and ...
<p><i>A</i>, Enhanced infection of SeV by neutralization of constitutive IFN-α visualized with IF. C...
(A-D) BMDMs from WT, MAVS-/-, or IFNAR-/- mice were mock infected or infected with WT or N1347A MHV,...
(A-B) TMZR5 GFP-reporter cells were challenged with matched TF and CC VSV-G pseudotyped IMC pairs an...
<p>(A–C) HDF-TERT cells were infected with <i>dl</i>309 (A), Ad5-WT (B) or Ad5-mut1 (C) at 25 virus ...